directoratelogoJ Duffy, C Webster

Department of Clinical Biochemistry and Immunology, Heartlands Hospital, Bordesley Green East, Birmingham, UK.

Introduction:  Vitamin D status is commonly assessed by measuring the concentration of 25OH vitamin D in serum.  LC-MS/MS has recently become the method of choice for its measurement.

The method described here is a gradient LC-MS/MS method which is both quick and precise and has excellent sensitivity.

Method:  Serum samples were initially precipitated with methanol containing deuterated vitamin D3 (internal standard).  The samples were then submitted to a single hexane extraction and evaporated to dryness.  Samples were reconstituted in 50:50 Methanol:water and 60uL injected onto a Luna C8(2) Mercury Cartridge 20x2mm (Phenomenex).  HPLC was performed using a gradient elution starting with 70% B and increasing to 95% B over 0.5 minutes.  Mobile phase A was 0.1% formic acid in water, mobile phase B was 0.2% formic acid in methanol and the flow rate was 0.8ml/min.  Sample analysis was in positive mode on an API 3200 Q Trap(r) tandem mass spectrometer (Applied Biosystems, Warrington, UK) using an APCI ion source and transitions m/z 413.2>355.4, m/z 401.3>365.4 and m/z 407.4>371.4 for vitamin D2, D3 and deuterated D3 respectively.

Results:  Run time was 2.5 minutes in total with D2 eluting at 1.62 minutes and D3 at 1.60 minutes.  The method was linear up to 309nmol/L for D2 (r=0.9977) and 314nmol/L for D3 (r=0.9976).  Intra-assay variation at 5nmol/L was 25 % for D2 and 21% for D3.  Inter-assay variation was 10.2% and 11.0% for D2 and 4% and 11.2% for D3 at 15.6nmol/L and 43.9nmol/L respectively.

Conclusion:  The method described above is a rapid and sensitive gradient method for quantitation of 25 OH Vitamin D using APCI ionisation to increase sensitivity and decrease background noise.

Erasmus, Smit1, Shaz Ahmad1, Jonathan Ball2, Trudy Mason1, Steve Wilson1, Sarah Drury3, Geraldine Hartshorne3, Gerry Gilleran4, Steve Taylor4

  1. Public Health Laboratory, HPA Birmingham, Heartlands Hospital, Birmingham, UK
  2. The Institute of Infection, Immunity and Inflammation, The University of Nottingham, Nottingham, UK
  3. Centre for Reproductive Medicine, University Hospital, Coventry, UK
  4. Dept of GU Medicine, Heartlands Hospital, Birmingham, UK

Background

The risk of transmission of HIV from a male to his sexual partner is related to the amount of virus in his semen. None of the commercial HIV-1 viral load assays are licensed for samples other than blood plasma and all current methods for seminal plasma viral loads are based on adaptation and validation of commercial assays. We developed and validated the performance of an easy to use, small volume, single sample automated extraction method as the front end of a normal HIV-1 viral load assay. This method will enable processing of small numbers of semen samples at a time and assay concurrently with normal blood plasma HIV-1 viral load testing.

Methods

MagNA Pure CompactTM extraction followed by the Roche COBAS TaqmanTM HIV detection was optimised for input, elution and QS volumes. Various dilution panels were made by spiking known quantities of HIV-1 into HIV negative seminal plasma. Specificity was evaluated by repeat testing of HIV negative seminal plasma. The limit of detection (LOD) was determined by testing 10, 15 and 15 spiked seminal plasmas with an expected viral load of 400, 200 and 100 copies/ml. Finally a comparison with a previous published method (TNAI COBAS Ampliprep/Cobas TaqmanTM) was performed. Correlation coefficient, scatter graphs and Bland Altmanns comparisons were used in the statistical analysis.

Results

No inhibition was observed in any of the specimens tested. There was good linearity and correlation (R2=0.97) between the expected and observed values for the dilution series. The reproducibility was within acceptable limits with the highest coefficient of variation (0.35) observed at the LOD of the assay. The LOD was at least 100 copies/ml and the assay specificity was 100%.  There was a good comparison (R2= 0.87) between the MagNA Pure Compact and TNAI extraction methods. Bland Altmanns plots showed that Compact gave on average 0.31 of log10 copies lower reading.

Conclusions

The MagNA Pure Compact is a single sample automated extraction method which can be used as the front end of the COBAS TaqmanTM HIV-1 quantitative PCR in seminal plasma.

Transport of Samples to Laboratories